Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients

Digestive Diseases and Sciences

Volumn 62, Issue 4, 2017, Pages 1058-1066

  Shalimar, ^a   Kedia, Saurabh ^a   Gunjan, Deepak ^a   Sonika, Ujjwal ^a   Mahapatra, Soumya Jagannath ^a   Nayak, Baibaswata ^a   Kaur, Harpreet ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

ALF; Cerebral edema; Hepatitis A virus; Liver transplant; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; UREA;

ACUTE LIVER FAILURE; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; BRAIN EDEMA; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE COURSE; END STAGE LIVER DISEASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS E; HEPATITIS NON A TO E; HOSPITALIZATION; HUMAN; INDIAN; INFECTION; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTHROMBIN TIME; SEIZURE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURVIVAL; SURVIVAL RATE; UREA BLOOD LEVEL; ADOLESCENT; COMPLICATION; EPIDEMIOLOGY; HEPATITIS E VIRUS; INDIA; LIVER FAILURE, ACUTE; MIDDLE AGED; RETROSPECTIVE STUDY; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INDIA; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 85010791823     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-017-4461-x     Document Type: Article

References (34)

1. Kumar R, Shalimar, Bhatia V, et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology. 2010;51:1665–1674.
2. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23:1448–1455.
3. Shalimar, Acharya SK, William ML. Worldwide differences in acute liver failure. In: Critical care in acute liver failure. Future Medicine Ltd; 2013 [cited 2016 May 14]. pp 32–46. http://www.futuremedicine.com/doi/abs/10.2217/ebo.12.326
4. Lee WM. Acute liver failure. Semin Respir Crit Care Med. 2012;33:36–45.
5. Acharya SK, Panda SK. Hepatitis E: water, water everywhere—now a global disease. J Hepatol. 2011;54:9–11.
6. Fontana RJ, Engle RE, Scaglione S, et al. The role of hepatitis E virus infection in adult Americans with acute liver failure. Hepatology. 2016;64:1870–1880.
7. Manka P, Bechmann LP, Coombes JD, et al. Hepatitis E virus infection as a possible cause of acute liver failure in Europe. Clin Gastroenterol Hepatol. 2015;13:1836–1842.
8. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55:988–997.
9. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388:1081–1088.
10. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10:61–69.
11. Reuben A, Tillman H, Fontana RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016;164:724–732.
12. Riegler JL, Lake JR. Fulminant hepatic failure. Med Clin North Am. 1993;77:1057–1083.
13. O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.
14. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.
15. Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplant-free survival of patients with acute liver failure. Clin Gastroenterol Hepatol. 2016;14:1199.e2–1206.e2.
16. Kumar R, Shalimar Sharma H, Goyal R, Kumar A, Khanal S, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–1075.
17. Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol. 1994;42:133–137.
18. Jameel S, Durgapal H, Habibullah CM, Khuroo MS, Panda SK. Enteric non-A, non-B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol. 1992;37:263–270.
19. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med. 1981;70:252–255.
20. Rab MA, Bile MK, Mubarik MM, et al. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: a common source outbreak traced to the malfunction of a modern water treatment plant. Am J Trop Med Hyg. 1997;57:151–157.
21. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008;48:1577–1585.
22. Shalimar, Acharya SK. Hepatitis e and acute liver failure in pregnancy. J Clin Exp Hepatol. 2013;3:213–224.
23. Aggarwal R. Hepatitis E: epidemiology and natural history. J Clin Exp Hepatol. 2013;3:125–133.
24. Shalimar, Kumar D, Vadiraja PK, et al. Acute on chronic liver failure because of acute hepatic insults: etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol. 2016;31:856–864.
25. Shalimar, Saraswat V, Singh S, et al. Acute on chronic liver failure in India: the INASL Consortium experience. J Gastroenterol Hepatol. 2016;31:1742–1749.
26. Nair VP, Anang S, Subramani C, et al. Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus. PLoS Pathog. 2016;12:e1005521.
27. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24:1484–1493.
28. Viral Hepatitis Surveillance—India, 2011–2013. [cited 2016 Jun 10]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a3.htm?s_cid=mm6428a3_w
29. Speiser JL, Lee WM, Karvellas CJ, US Acute Liver Failure Study Group. Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PloS One. 2015;10:e0122929.
30. Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynaecol Obstet. 2001;72:103–108.
31. Beniwal M, Kumar A, Kar P, Jilani N, Sharma JB. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from north India. Indian J Med Microbiol. 2003;21:184–185.
32. Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.
33. Louvet A, Labreuche J, Artru F, et al. Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology. 2015;149:398.e8–406.e8.
34. McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–499.